Pfizer Past Earnings image   This PFE past earnings page last updated 11/3/2022
Pfizer Past Earnings
PeriodPast Earnings DateAdj. EPS
Q3 202211/1/20221.780
Q2 20227/28/20222.040
Q1 20225/3/20221.620
Q4 20212/8/20221.080
Q3 202111/2/20211.340
Q2 20217/28/20211.070
Q1 20215/4/20210.930
Q4 20202/2/20210.420
Q3 202010/27/20200.720
Q2 20207/28/20200.780
Q1 20204/28/20200.800
Q4 20191/28/20200.550
Q3 201910/29/20190.750
Q2 20197/29/20190.800
Q1 20194/30/20190.850
Q4 20181/29/20190.64
Q3 201810/30/20180.78
Q2 20187/31/20180.81
Q1 20185/1/20180.77
Q4 20171/30/20180.62
Q3 201710/31/20170.67
Q2 20178/1/20170.67
Q1 20175/2/20170.69
Q4 20161/31/20170.47
Q3 201611/1/20160.61
Q2 20168/2/20160.64
Q1 20165/3/20160.67
Q4 20152/2/20160.53
Q3 201510/27/20150.6
Q2 20157/28/20150.56
Q1 20154/28/20150.51
Q4 20141/27/20150.54
Q3 201410/28/20140.57
Q2 20147/29/20140.58
Q1 20145/5/20140.57
Q4 20131/28/20140.56
Q3 201310/29/20130.58
Q2 20137/30/20130.56
Q1 20134/30/20130.54
Q4 20121/29/20130.47
Q3 201211/1/20120.53
Q2 20127/31/20120.62
Q1 20124/26/20120.24
Pfizer Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/1/202222.64B
Q2 20227/28/202227.74B
Q1 20225/3/202225.66B
Q4 20212/8/202223.84B
Q3 202111/2/202124.09B
Q2 20217/28/202118.98B
Q1 20215/4/202114.58B
Q4 20202/2/202111.68B
Q3 202010/27/202012.13B
Q2 20207/28/202011.80B
Q1 20204/28/202012.03B
Q4 20191/28/202012.69B
Q3 201910/29/201912.68B
Q2 20197/29/201913.26B
Q1 20194/30/201913.12B
Q4 20181/29/201913.98B
Q3 201810/30/201813.30B
Q2 20187/31/201813.47B
Q1 20185/1/201812.91B
Q4 20171/30/201813.70B
Q3 201710/31/201713.17B
Q2 20178/1/201712.90B
Q1 20175/2/201712.78B
Q4 20161/31/201713.63B
Q3 201611/1/201613.04B
Q2 20168/2/201613.15B
Q1 20165/3/201613.01B
Q4 20152/2/201614.05B
Q3 201510/27/201512.09B
Q2 20157/28/201511.85B
Q1 20154/28/201510.86B
Q4 20141/27/201513.12B
Q3 201410/28/201412.36B
Q2 20147/29/201412.80B
Q1 20145/5/201411.40B
Q4 20131/28/201413.56B
Q3 201310/29/201312.64B
Q2 20137/30/201312.97B
Q1 20134/30/201313.50B
Q4 20121/29/201315.10B
Q3 201211/1/201213.98B
Q2 20127/31/201215.50B
Q1 20124/26/201214.88B
Quotes delayed 20 minutes

Email EnvelopeFree PFE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Pfizer (PFE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PGEN Past Earnings
PGNY Past Earnings
PHAS Past Earnings
PHAT Past Earnings
PHIO Past Earnings
PKI Past Earnings
PLRX Past Earnings
PLSE Past Earnings
PLXP Past Earnings
PMCB Past Earnings

PFE Past Earnings Q&A

What was the best and worst PFE past earnings results?
For Pfizer, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PFE past earnings result in our data set was 2.040/share posted in Q2 2022, while the lowest was in Q1 2012 when PFE posted 0.24/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when PFE reported 27.74B in revenue, while the quarter with the lowest revenue in our data set was Q1 2015 at 10.86B of revenue.

  Suggested answer: There are 43 PFE past earnings results in our data set.

On this page we presented the PFE past earnings date information for Pfizer. Reviewing that Pfizer Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2022, when PFE posted adjusted EPS of 2.040/share. Meanwhile the lowest PFE past earnings result was in Q1 2012, when PFE posted adjusted EPS of 0.24/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when PFE reported 27.74B in revenue, while the smallest revenue quarter was Q1 2015 when PFE reported 10.86B in revenue.

Any self directed investor doing their due diligence on PFE or any other given stock can benefit from researching all of the Pfizer past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Pfizer past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PFE. Thanks for visiting, and the next time you need to research PFE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding FCRM, Institutional Holders of GLYC, AAP Dividend Growth Rate.

 

Pfizer Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.